165 related articles for article (PubMed ID: 22385508)
1. EDITORIAL: Molecularly targeted treatments for colorectal cancer: advances and limitations.
Parodi S
Curr Cancer Drug Targets; 2012 May; 12(4):301-2. PubMed ID: 22385508
[No Abstract] [Full Text] [Related]
2. Novel Wnt signaling and other pathway inhibitors in the colorectal cancer genomic landscape era.
Roukos DH; Ziogas DE; Papaloukas C; Baltogiannis G
Future Oncol; 2012 Nov; 8(11):1373-6. PubMed ID: 23148609
[No Abstract] [Full Text] [Related]
3. Molecular Triage Trials in Colorectal Cancer.
O'Hara MH; Hamilton SR; O'Dwyer PJ
Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
[TBL] [Abstract][Full Text] [Related]
4. Developing novel and highly effective new therapeutic strategies for treatment of colorectal cancer: where do we go from here?
Houghton JA
Curr Opin Investig Drugs; 2001 May; 2(5):674-6. PubMed ID: 11569946
[No Abstract] [Full Text] [Related]
5. Novel and Emerging Targeted Therapies of Colorectal Cancer.
Finnberg N; Gokare P; El-Deiry WS
Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
[TBL] [Abstract][Full Text] [Related]
6. Targeted treatments in colorectal cancer: state of the art and future perspectives.
Arnold D; Seufferlein T
Gut; 2010 Jun; 59(6):838-58. PubMed ID: 20551469
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic Therapy in Colorectal Cancer.
Mody K; Baldeo C; Bekaii-Saab T
Cancer J; 2018; 24(4):165-170. PubMed ID: 30119079
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy in first line treatment of RAS wild type colorectal cancer.
Formica V; Roselli M
World J Gastroenterol; 2015 Mar; 21(10):2871-4. PubMed ID: 25780283
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
Molloy MP; Engel A
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
[No Abstract] [Full Text] [Related]
10. Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment.
Roukos DH; Katsios C; Liakakos T
Expert Rev Mol Diagn; 2010 Jul; 10(5):541-5. PubMed ID: 20629500
[No Abstract] [Full Text] [Related]
11. Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer.
Ko SY; Blatch GL; Dass CR
Cancer Metastasis Rev; 2014 Mar; 33(1):101-13. PubMed ID: 24338005
[TBL] [Abstract][Full Text] [Related]
12. [Progress of targeted therapy related to K-ras mutation].
Li ZW; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):59-61. PubMed ID: 22455857
[No Abstract] [Full Text] [Related]
13. Emerging drugs in refractory colorectal cancer.
Nobili S; Galletta A; Brugia M; Tassi R; Petreni P; Landini I; Mini E
Future Med Chem; 2015 Aug; 7(12):1491-501. PubMed ID: 26293581
[TBL] [Abstract][Full Text] [Related]
14. The challenge to optimize medical therapy for advanced colorectal cancer.
Hubbard JM; Grothey A
J Natl Cancer Inst; 2014 Feb; 106(2):djt442. PubMed ID: 24511110
[No Abstract] [Full Text] [Related]
15. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
McDonald SL; Silver AR
Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
[TBL] [Abstract][Full Text] [Related]
16. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Cohen SJ; Cohen RB; Meropol NJ
J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
[TBL] [Abstract][Full Text] [Related]
17. [Targeting the RAS signalling pathway in cancer].
Mansi L; Viel E; Curtit E; Medioni J; Le Tourneau C
Bull Cancer; 2011 Oct; 98(9):1019-28. PubMed ID: 21715253
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and targeted therapeutics in colorectal cancer.
Meguerditchian AN; Bullard Dunn K
Surg Oncol Clin N Am; 2013 Oct; 22(4):841-55. PubMed ID: 24012402
[TBL] [Abstract][Full Text] [Related]
19. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities.
Porru M; Pompili L; Caruso C; Biroccio A; Leonetti C
J Exp Clin Cancer Res; 2018 Mar; 37(1):57. PubMed ID: 29534749
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.
Balakrishnan A; Vyas A; Deshpande K; Vyas D
World J Gastroenterol; 2016 Feb; 22(7):2159-64. PubMed ID: 26900281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
